 |
 |
...continued from part 1 of 2... Bezard E, et al. Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Prog Neurobiol. 1998 Jun; 55(2): 93-116. PMID: 9618745; UI: 98282467. Malapani C, et al. Coupled Temporal Memories in Parkinson's Disease. A Dopamine-Related Dysfunction. J Cogn Neurosci. 1998 May 22; 10(3): 316-331. PMID: 9618592. Ingham CA, et al. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci. 1998 Jun 15; 18(12): 4732-4743. PMID: 9614247; UI: 98279083. Knopman DS. The initial recognition and diagnosis of dementia. Am J Med. 1998 Apr 27; 104(4A): 2S-12S. Review. PMID: 9617846; UI: 98278408. Glozman JM, et al. Scale of quality of life of care-givers. J Neurol. 1998 May; 245 Suppl 1: S39-S41. PMID: 9617723; UI: 98280717. Martinez-Martin P, et al. Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. J Neurol. 1998 May; 245 Suppl 1: S34-S38. PMID: 9617722; UI: 98280716. Grandas F, et al. Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR study. The STAR Multicenter Study Group. J Neurol. 1998 May; 245 Suppl 1: S31-S33. PMID: 9617721; UI: 98280715. Wasielewski PG, et al. Quality of life and Parkinson's disease: the CR FIRST Study. J Neurol. 1998 May; 245 Suppl 1: S28-S30. PMID: 9617720; UI: 98280714. Henneberg A. Additional therapies in Parkinson's disease patients: useful tools for the improvement of the quality of life or senseless loss of resources? J Neurol. 1998 May; 245 Suppl 1: S23-S27. PMID: 9617719; UI: 98280713. MacMahon DG, et al. Practical approach to quality of life in Parkinson's disease: the nurse's role. J Neurol. 1998 May; 245 Suppl 1: S19-S22. PMID: 9617718; UI: 98280712. Stocchi F, et al. Sleep disorders in Parkinson's disease. J Neurol. 1998 May; 245 Suppl 1: S15-S18. PMID: 9617717; UI: 98280711. Peto V, et al. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol. 1998 May; 245 Suppl 1: S10-S14. PMID: 9617716; UI: 98280710. Baker MG. From the moment of diagnosis. J Neurol. 1998 May; 245 Suppl 1: S7-S9. PMID: 9617715; UI: 98280709. Martinez-Martin P. An introduction to the concept of "quality of life in Parkinson's disease". J Neurol. 1998 May; 245 Suppl 1: S2-S6. PMID: 9617714; UI: 98280708. McGeer EG, et al. The future use of complement inhibitors for the treatment of neurological diseases. Drugs. 1998 Jun; 55(6): 739-746. PMID: 9617589; UI: 98280583. Schrag AE, et al. The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease. Clin Neuropharmacol. 1998 May; 21(3): 169-175. PMID: 9617508; UI: 98280502. van der Geest R, et al. Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease. Clin Neuropharmacol. 1998 May; 21(3): 159-168. PMID: 9617507; UI: 98280501. van Laar T, et al. Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease. Clin Neuropharmacol. 1998 May; 21(3): 152-158. PMID: 9617506; UI: 98280500. Piercey MF. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease. Clin Neuropharmacol. 1998 May; 21(3): 141-151. PMID: 9617505; UI: 98280499. Briars R. Communication breakdown. Nurs Stand. 1998 Apr 1; 12(28): 18. No abstract available. PMID: 9616619; UI: 98279591. Kerschan K, et al. [No title available]. Wien Klin Wochenschr. 1998 Apr 24; 110(8): 279-286. German. PMID: 9615959; UI: 98278193. Mandel RJ, et al. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J Neurosci. 1998 Jun 1; 18(11): 4271-4284. PMID: 9592104; UI: 98256394. Fox SH, et al. Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Exp Neurol. 1998 May; 151(1): 35-49. PMID: 9582253; UI: 98250832. Mandanas L. Management of Parkinson disease. J Am Board Fam Pract. 1998 Mar; 11(2): 171. No abstract available. PMID: 9542714; UI: 98203841. Boraud T, et al. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res. 1998 Mar 16; 787(1): 157-160. PMID: 9518590; UI: 98186741. Zubenko GS, et al. Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome. Am J Med Genet. 1998 Mar 28; 81(2): 196-205. PMID: 9613863; UI: 98273944. Kunugi H, et al. Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease. Am J Med Genet. 1998 Mar 28; 81(2): 131-133. PMID: 9613851; UI: 98273932. Meara J, et al. Sertraline for the treatment of depression in Parkinson's disease. Mov Disord. 1998 May; 13(3): 622. No abstract available. PMID: 9613775; UI: 98273831. Djaldetti R, et al. Extreme anticipation in young-onset Parkinson's disease. Mov Disord. 1998 May; 13(3): 599-600. No abstract available. PMID: 9613762; UI: 98273818. Fernandez HH, et al. Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Mov Disord. 1998 May; 13(3): 597-598. No abstract available. PMID: 9613761; UI: 98273817. Speelman JD, et al. Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective. Mov Disord. 1998 May; 13(3): 582-588. PMID: 9613759; UI: 98273815. Adler CH, et al. Olfactory function in restless legs syndrome. Mov Disord. 1998 May; 13(3): 563-565. PMID: 9613755; UI: 98273811. Caviness JN, et al. Cortical myoclonus in levodopa-responsive parkinsonism. Mov Disord. 1998 May; 13(3): 540-544. PMID: 9613750; UI: 98273806. O'Sullivan JD, et al. Apomorphine-induced penile erections in Parkinson's disease. Mov Disord. 1998 May; 13(3): 536-539. PMID: 9613749; UI: 98273805. Merello M, et al. Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test. Mov Disord. 1998 May; 13(3): 533-535. PMID: 9613748; UI: 98273804. Pang CP, et al. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease. Mov Disord. 1998 May; 13(3): 529-532. PMID: 9613747; UI: 98273803. Elble RJ. Tremor in ostensibly normal elderly people. Mov Disord. 1998 May; 13(3): 457-464. PMID: 9613737; UI: 98273793. Marti-Masso JF, et al. Cinnarizine-induced parkinsonism: ten years later. Mov Disord. 1998 May; 13(3): 453-456. PMID: 9613736; UI: 98273792. Delalande I, et al. Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy? Mov Disord. 1998 May; 13(3): 446-452. PMID: 9613735; UI: 98273791. Wenning GK, et al. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease. Mov Disord. 1998 May; 13(3): 438-445. PMID: 9613734; UI: 98273790. Hausdorff JM, et al. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord. 1998 May; 13(3): 428-437. PMID: 9613733; UI: 98273789. Oliveira RM, et al. Hypometria in Parkinson's disease: automatic versus controlled processing. Mov Disord. 1998 May; 13(3): 422-427. PMID: 9613732; UI: 98273788. Agostino R, et al. Clinical impairment of sequential finger movements in Parkinson's disease. Mov Disord. 1998 May; 13(3): 418-421. PMID: 9613731; UI: 98273787. Verhagen Metman L, et al. A trial of dextromethorphan in parkinsonian patients with motor response complications. Mov Disord. 1998 May; 13(3): 414-417. PMID: 9613730; UI: 98273786. Chrischilles EA, et al. The health burdens of Parkinson's disease. Mov Disord. 1998 May; 13(3): 406-413. PMID: 9613729; UI: 98273785. Chio A, et al. Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord. 1998 May; 13(3): 400-405. PMID: 9613728; UI: 98273784. Potagas C, et al. Clinical assessment of olfactory dysfunction in Parkinson's disease. Mov Disord. 1998 May; 13(3): 394-399. PMID: 9613727; UI: 98273783. Kordower JH, et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord. 1998 May; 13(3): 383-393. PMID: 9613726; UI: 98273782. Trosch RM, et al. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience. Mov Disord. 1998 May; 13(3): 377-382. PMID: 9613725; UI: 98273781. Kordower JH, et al. Neuropathology of fetal nigral grafts in patients with Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 88-95. No abstract available. PMID: 9613724; UI: 98273780. Lindvall O. Update on fetal transplantation: the Swedish experience. Mov Disord. 1998; 13 Suppl 1: 83-87. PMID: 9613723; UI: 98273779. Kumar R, et al. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 73-82. PMID: 9613722; UI: 98273778. Kang UJ. Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies. Mov Disord. 1998; 13 Suppl 1: 59-72. PMID: 9613721; UI: 98273777. Olanow CW, et al. Current status of selegiline as a neuroprotective agent in Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 55-58. No abstract available. PMID: 9613720; UI: 98273776. Lapchak PA. A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 49-54. PMID: 9613719; UI: 98273775. Shoulson I. Where do we stand on neuroprotection? Where do we go from here? Mov Disord. 1998; 13 Suppl 1: 46-48. PMID: 9613718; UI: 98273774. Hirsch EC, et al. Iron metabolism and Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 39-45. PMID: 9613717; UI: 98273773. Przedborski S, et al. Mechanisms of MPTP toxicity. Mov Disord. 1998; 13 Suppl 1: 35-38. PMID: 9613716; UI: 98273772. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 24-34. PMID: 9613715; UI: 98273771. Burke RE. Programmed cell death and Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 17-23. No abstract available. PMID: 9613714; UI: 98273770. Logroscino G, et al. Dietary iron, animal fats, and risk of Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 13-16. PMID: 9613713; UI: 98273769. Duvoisin RC. Role of genetics in the cause of Parkinson's disease. Mov Disord. 1998; 13 Suppl 1: 7-12. No abstract available. PMID: 9613712; UI: 98273768. Fahn S, et al. Highlights of the Parkinson's Disease Foundation. Mov Disord. 1998; 13 Suppl 1: 2-6. No abstract available. PMID: 9613711; UI: 98273767. Braune S, et al. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand. 1998 May; 97(5): 307-314. PMID: 9613560; UI: 98273616. Iwasa K, et al. Decreased myocardial 123I-MIBG uptake in Parkinson's disease. Acta Neurol Scand. 1998 May; 97(5): 303-306. PMID: 9613559; UI: 98273615. Zipp F, et al. Glutamine synthetase activity in patients with Parkinson's disease. Acta Neurol Scand. 1998 May; 97(5): 300-302. PMID: 9613558; UI: 98273614. Pierelli F, et al. Low dosage clozapine effects on L-dopa induced dyskinesias in parkinsonian patients. Acta Neurol Scand. 1998 May; 97(5): 295-299. PMID: 9613557; UI: 98273613. Rubenstein LM, et al. The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research. Qual Life Res. 1998 May; 7(4): 279-290. PMID: 9610212; UI: 98273132. Losonczy KG, et al. Prevalence and correlates of dementia: survey of the last days of life. Public Health. 1998 May; 113(3): 273-280. PMID: 9610210; UI: 98273130. Yokoyama T, et al. Localizing pallidotomy lesions. J Neurosurg. 1998 Jun; 88(6): 1125-1126. No abstract available. PMID: 9609317; UI: 98270480. Chodakiewitz JW. Localizing pallidotomy lesions. J Neurosurg. 1998 Jun; 88(6): 1125. No abstract available. PMID: 9609316; UI: 98270479. Ross DA. Thalamotomy for parkinsonian tremor. J Neurosurg. 1998 Jun; 88(6): 1121-1122. No abstract available. PMID: 9609313; UI: 98270476. Mehta V, et al. Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line- derived neurotrophic factor. J Neurosurg. 1998 Jun; 88(6): 1088-1095. PMID: 9609305; UI: 98270468. Duma CM, et al. Gamma knife radiosurgery for thalamotomy in parkinsonian tremor: a five-year experience. J Neurosurg. 1998 Jun; 88(6): 1044-1049. PMID: 9609299; UI: 98270462. Vitek JL, et al. Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. J Neurosurg. 1998 Jun; 88(6): 1027-1043. PMID: 9609298; UI: 98270461. Yoshida K, et al. Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog Neuropsychopharmacol Biol Psychiatry. 1998 Feb; 22(2): 435-444. PMID: 9608612; UI: 98271539. Parsa MA, et al. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1998; 10(2): 216-219. PMID: 9608412; UI: 98271339. Roane DM, et al. Delusional misidentification in association with parkinsonism. J Neuropsychiatry Clin Neurosci. 1998; 10(2): 194-198. PMID: 9608408; UI: 98271335. Moellentine C, et al. Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci. 1998; 10(2): 187-193. PMID: 9608407; UI: 98271334. Imaoka T, et al. Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA- liposome complex. Hum Gene Ther. 1998 May 1; 9(7): 1093-1102. PMID: 9607420; UI: 98268436. Zhuchenko TD, et al. [Vascular parkinsonism]. Zh Nevrol Psikhiatr Im S S Korsakova. 1998; 98(4): 62-65. Russian. No abstract available. PMID: 9606903; UI: 98269748. Baziian BKh, et al. [Possible mechanism of disturbances of saccadic eye movements in patients with Parkinson disease]. Biull Eksp Biol Med. 1998 Mar; 125(3): 254-259. Russian. No abstract available. PMID: 9606536; UI: 98269381. Bourke D, et al. Possible association between donepezil and worsening Parkinson's disease. Ann Pharmacother. 1998 May; 32(5): 610-611. No abstract available. PMID: 9606486; UI: 98269331. Goldman WP, et al. Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia. Arch Neurol. 1998 May; 55(5): 674-680. PMID: 9605724; UI: 98266761. Kanemaru K, et al. Cerebrospinal fluid homovanillic acid levels are not reduced in early corticobasal degeneration. Neurosci Lett. 1998 Apr 3; 245(2): 121-122. PMID: 9605500; UI: 98266537. Jin BK, et al. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Neurosci Lett. 1998 Apr 3; 245(2): 61-64. PMID: 9605485; UI: 98266522. Rozas G, et al. Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice. Neurosci Lett. 1998 Apr 10; 245(3): 151-154. PMID: 9605478; UI: 98266515. Sandyk R. Reversal of a body image disorder (macrosomatognosia) in Parkinson's disease by treatment with AC pulsed electromagnetic fields. Int J Neurosci. 1998 Feb; 93(1-2): 43-54. PMID: 9604168; UI: 98267527. Herishanu YO, et al. A case-referent study of extrapyramidal signs (preparkinsonism) in rural communities of Israel. Can J Neurol Sci. 1998 May; 25(2): 127-133. PMID: 9604134; UI: 98267493. Spillantini MG, et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A. 1998 May 26; 95(11): 6469-6473. PMID: 9600990; UI: 98263381. Corrigan FM, et al. Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp Neurol. 1998 Apr; 150(2): 339-342. PMID: 9527905; UI: 98197150. Palfi S, et al. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp Neurol. 1998 Apr; 150(2): 272-281. PMID: 9527897; UI: 98197142. Hawkes CH, et al. Olfactory disorder in motor neuron disease. Exp Neurol. 1998 Apr; 150(2): 248-253. PMID: 9527894; UI: 98197139. Duty S, et al. Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat. Exp Neurol. 1998 Apr; 150(2): 223-234. PMID: 9527891; UI: 98197136. Maruyama W, et al. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide. J Neurochem. 1998 Jun; 70(6): 2510-2515. PMID: 9603216; UI: 98264355.